IBEX Ltd 2024年度报告

(Mark One) xANNUAL REPORT PURSUANT TO SECTION13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934For the fiscalyear endedJune30, 2025 OR oTRANSITION REPORT PURSUANT TO SECTION13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934For the transition period from ________ to ________ IBEX LIMITED (Exact name of Registrant as specified in its charter) 00-0000000 (State or Other Jurisdiction of Incorporation or Organization)(I.R.S. Employer Identification No.) Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule405 of the Securities Act. Indicate by check mark if the registrant is not required to file reports pursuant to Section13 or Section15(d) of the Act. Indicate by check mark whether the registrant (1)has filed all reports required to be filed by Section13 or 15(d)of the Securities Exchange Act of1934 during the preceding 12months (or for such shorter period that the registrant was required to file such reports), and (2)has been subject tosuch filing requirements for the past 90days. Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant toRule405 of Regulation S-T (§232.405 of this chapter) during the preceding 12months (or for such shorter period that the registrant was requiredto submit such files). oNo Table ofContents Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reportingcompany, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and“emerging growth company” in Rule 12b-2 of the Exchange Act: If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying withany new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Acto Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of itsinternal control over financial reporting under Section404(b)of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accountingfirm that prepared or issued its audit report.o If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant includedin the filing reflect the correction of an error to previously issued financial statements.o Indicateby check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-basedcompensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b).o Indicate by check mark whether the registrant is a shell company (as defined in Rule12b-2 of the Exchange Act). xNo As of December 31, 2024, the last business day of the registrant’s most recently completed second fiscal quarter, there were 13,181,524common shares outstanding. The aggregate market value of the registrant’s voting and non-voting common equity that was held by non-affiliateson such date was approximately $226,110,774based on the closing sale price of the registrant’s common shares on such date as reported onthe Nasdaq Global Market. The registrant had13,315,077common shares outstanding as of August29, 2025. DOCUMENTS INCORPORATED BY REFERENCE Portions of our definitive proxy statement relating to our next Annual Meeting of Shareholders are incorporated herein by references in Part III ofthis Annual Report on Form 10-K to the extent stated herein. IBEX LIMITED TABLE OF CONTENTS CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS4PARTI7ITEM1.BUSINESS7ITEM1A.RISK FACTORS21ITEM 1B.UNRESOLVED STAFF COMMENTS40ITEM 1C.CYBERSECURITY40ITEM 2.PROPERTIES42ITEM3.LEGAL PROCEEDINGS43ITEM4.MINE SAFETY DISCLOSURES43PARTII43ITEM 5.MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OFEQUITY SECURITIES43ITEM6.[RESERVED]44ITEM 7.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS44ITEM 7A.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK61ITEM 8.FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA63ITEM 9.CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE98ITEM9A.CONTROLS AND PROCEDURES98ITEM 9B.OTHER INFORMATION99ITEM 9C.DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS99PARTIII99ITEM10.DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE99ITEM 11.EXECUTIVE COMPENSATION99ITEM 12.SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS99ITEM 13.CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE99ITEM 14.PRINCIPAL ACCOUNTANT FEES AND SERVICES100PARTIV100ITEM 15EXHIBITS AND FINANCIAL STATEMENT SCHEDULES100ITEM16.FORM 10-K SUMMARY103SIGNATURES104 CAUTIONARY NOTE REGA